What does CUSIP 44930G107 represent in this 13F holders report?

CUSIP 44930G107 is the security identifier for ICUI - ICU MEDICAL INC/DE - Common Stock used to aggregate holder disclosures.

How many institutions held ICUI - ICU MEDICAL INC/DE - Common Stock in Q1 2021?

277 institutional investors reported ICUI - ICU MEDICAL INC/DE - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

ICU MEDICAL INC/DE - Common Stock (ICUI)

CUSIP: 44930G107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 24,701,460
Total 13F shares: 20,080,347
Share change: +567,922
Total reported value: $4,125,473,068
Put/Call ratio: 28%
Price per share: $205.44
Number of holders: 277
Value change: +$114,043,017
Number of buys: 131
Number of sells: 119

Quarterly Holders Quick Answers

What is CUSIP 44930G107?
CUSIP 44930G107 identifies ICUI - ICU MEDICAL INC/DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 44930G107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ICUI - ICU MEDICAL INC/DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	11%	2,640,364	$566,332,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	11%	2,623,694	$562,756,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	7.3%	1,805,362	$387,232,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	6.7%	1,660,914	$356,249,000	—	31 Dec 2020	13F
NUANCE INVESTMENTS, LLC	13F	Company	3.6%	901,483	$193,359,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	3.1%	771,746	$165,532,000	—	31 Dec 2020	13F
Findlay Park Partners LLP	13F	Company	2.1%	528,825	$113,428,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	2%	495,962	$106,379,000	—	31 Dec 2020	13F
Nitorum Capital, L.P.	13F	Company	1.7%	417,241	$89,494,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.6%	405,201	$86,912,000	—	31 Dec 2020	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	1.5%	370,610	$79,492,000	—	31 Dec 2020	13F
ATLANTA CAPITAL MANAGEMENT CO L L C	13F	Company	1.4%	334,418	$71,729,000	—	31 Dec 2020	13F
Neuberger Berman Group LLC	13F	Company	1.2%	287,173	$61,592,000	—	31 Dec 2020	13F
EATON VANCE MANAGEMENT	13F	Company	1.1%	283,895	$60,893,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	1.1%	267,817	$57,444,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	246,923	$52,962,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.98%	242,511	$52,016,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	0.98%	241,454	$51,789,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.86%	211,757	$45,420,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.81%	200,294	$42,961,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.81%	199,750	$42,845,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.75%	184,891	$39,657,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.71%	174,399	$37,407,000	—	31 Dec 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.63%	156,513	$33,570,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.62%	153,983	$33,028,000	—	31 Dec 2020	13F
Boston Trust Walden Corp	13F	Company	0.51%	125,556	$26,930,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.51%	125,217	$26,857,000	—	31 Dec 2020	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.5%	124,588	$26,722,000	—	31 Dec 2020	13F
GW&K Investment Management, LLC	13F	Company	0.5%	124,002	$26,597,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.46%	113,203	$24,282,000	—	31 Dec 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.38%	94,551	$20,280,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	93,249	$20,001,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.35%	85,631	$18,367,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.34%	84,674	$18,086,000	—	31 Dec 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.31%	77,669	$16,558,000	—	31 Dec 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.3%	75,045	$16,096,000	—	31 Dec 2020	13F
GLENMEDE TRUST CO NA	13F	Company	0.3%	74,591	$15,998,000	—	31 Dec 2020	13F
Tamarack Advisers, LP	13F	Company	0.3%	73,000	$15,452,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.28%	69,259	$14,855,000	—	31 Dec 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.27%	66,034	$14,162,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.26%	64,026	$13,733,000	—	31 Dec 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.25%	62,857	$13,482,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.25%	62,328	$13,369,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.24%	60,305	$12,935,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.24%	59,605	$12,785,000	—	31 Dec 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.24%	58,122	$12,466,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.23%	56,053	$12,023,000	—	31 Dec 2020	13F
GABELLI FUNDS LLC	13F	Company	0.2%	49,946	$10,713,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.2%	49,252	$10,564,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.2%	48,400	$10,381,000	—	31 Dec 2020	13F

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q1 2021

As of 31 Mar 2021, ICU MEDICAL INC/DE - Common Stock (ICUI) was held by 277 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,080,347 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., NUANCE INVESTMENTS, LLC, JPMORGAN CHASE & CO, Findlay Park Partners LLP, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, and ATLANTA CAPITAL MANAGEMENT CO L L C. This page lists 278 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

273

Q1 2021 holders

277

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.